Generated by AI
Anixa Biosciences, Inc. is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. The company develops cancer vaccines and cell-based immunotherapies, including programs centered on breast cancer, ovarian cancer, and other hard-to-treat solid tumors. Its work includes vaccine platforms designed to stimulate immune responses against cancer-related targets and a CAR-T-based therapeutic approach aimed at oncology applications. Anixa Biosciences also explores complementary diagnostics and related research programs that support early detection and cancer management. Headquartered in San Jose, California, Anixa Biosciences serves the biotechnology and oncology markets through a pipeline of current products and development programs that address unmet needs in cancer care.
Website3150 Almaden Expressway
San Jose, CA, 95118
United States
The latest articles about ANIX.
Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.
Summary of Jun 26's posts. Generated by AI.
Summary of Dec 11's posts. Generated by AI.
Summary of Apr 17's posts. Generated by AI.
Summary of Aug 25's posts. Generated by AI.
Investors talking about ANIX also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.